BRAIN Biotech AG
BNN.XETRA
| Exchange: | XETRA |
| Currency | Euro |
| ISIN: | DE0005203947 |
| LEI: | 391200JKPVHLD6JLZ107 |
| Primary Ticker: | BNN.XETRA |
| Fiscal Year End: | September |
| Sector: | Basic Materials |
| Industry: | Specialty Chemicals |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Biotechnology |
| Gic Sub Industry: | Biotechnology |
| Description: | BRAIN Biotech AG engages in the research and development of Bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. It operates in three segments: Bio Products, Bio Science, and Bio Incubator. The company offers enzymes and biocatalysts to produce food and beverages, wound care preparations or lubricants, and production of starch and bioethanol; and microorganisms as the functional biomass for optimized industrial production processes, recycling of the greenhouse gas CO2 as an industrial raw material, and urban and green mining for extraction of precious and rare earth metals. It also provides biocatalysts and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany. |
| Address: | Darmst Aedter Strasse 34-36, Zwingenberg, Germany, 64673 |
| Website: | https://www.brain-biotech.com |
| Full Time Employees: | 319 |
| Updated On: | 2024-11-04 |
Highlights
| Market Capitalization: | 56366548 |
| Market Capitalization Mln: | 56.36 |
| EBITDA: | -2346000 |
| Wall Street Target Price: | 13.52 |
| Book Value: | 0.74 |
| Earnings Share: | -0.41 |
| EPS Estimate Current Year: | -0.25 |
| EPS Estimate Next Year: | -0.19 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | -0.15 |
| Operating Margin TTM: | -0.16 |
| Return On Assets TTM: | -0.04 |
| Return On Equity TTM: | -0.41 |
| Revenue TTM: | 56262000 |
| Revenue Per Share TTM: | 2.57 |
| Gross Profit TTM: | 27608000 |
| Diluted Eps TTM: | -0.41 |
Valuation
| Price Sales TTM: | 1.00 |
| Price Book MRQ: | 3.59 |
| Enterprise Value: | 52693761 |
| Enterprise Value Revenue: | 0.95 |
| Enterprise Value Ebitda: | -35.36 |
Shares
| Shares Outstanding: | 21847500 |
| Shares Float: | 9062778 |
| Percent Insiders: | 60.62 |
| Percent Institutions: | 18.88 |
Technicals
| Beta: | 1.28 |
| 52 Week High: | 4.36 |
| 52 Week Low: | 1.41 |
| 50 Day MA: | 2.10 |
| 200 Day MA: | 2.69 |
Earnings
| Report Date: | 2025-05-26 |
| Date: | 2025-03-31 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Report Date: | 2025-02-26 |
| Date: | 2024-12-31 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Report Date: | 2019-05-29 |
| Date: | 2019-03-31 |
| Currency: | EUR |
| Eps Actual: | -0.15 |
| Report Date: | 2017-11-29 |
| Date: | 2017-09-30 |
| Currency: | EUR |
| Eps Actual: | -0.12 |
| Report Date: | 2017-08-30 |
| Date: | 2017-06-30 |
| Currency: | EUR |
| Eps Actual: | -0.10 |
| Report Date: | 2017-05-31 |
| Date: | 2017-03-31 |
| Currency: | EUR |
| Eps Actual: | -0.07 |
| Report Date: | 2017-03-01 |
| Date: | 2016-12-31 |
| Currency: | EUR |
| Eps Actual: | -0.27 |
| Report Date: | 2016-11-30 |
| Date: | 2016-09-30 |
| Currency: | EUR |
| Eps Actual: | -0.15 |
| Eps Estimate: | -0.1 |
| Eps Difference: | -0.05 |
| Surprise Percent: | -5 |
| Report Date: | 2016-08-31 |
| Date: | 2016-06-30 |
| Currency: | EUR |
| Eps Actual: | -0.15 |
| Report Date: | 2016-03-31 |
| Date: | 2016-03-31 |
| Currency: | EUR |
| Eps Actual: | -0.24 |
| Date: | 2023-09-30 |
| Period: | +1y |
| Growth: | 0.24 |
| Earnings Estimate Avg: | -0.19 |
| Earnings Estimate Low: | -0.37 |
| Earnings Estimate High: | 0.12 |
| Earnings Estimate Year Ago Eps: | -0.25 |
| Earnings Estimate Number Of Analysts: | 5.00 |
| Earnings Estimate Growth: | 0.24 |
| Revenue Estimate Avg: | 58470000.00 |
| Revenue Estimate Low: | 52000000.00 |
| Revenue Estimate High: | 67600000.00 |
| Revenue Estimate Number Of Analysts: | 7.00 |
| Revenue Estimate Growth: | 0.16 |
| Eps Trend Current: | -0.19 |
| Eps Trend7days Ago: | -0.19 |
| Eps Trend30days Ago: | -0.26 |
| Eps Trend60days Ago: | -0.26 |
| Eps Trend90days Ago: | -0.25 |
| Eps Revisions Up Last30days: | 1.00 |
| Date: | 2022-12-31 |
| Period: | +1q |
| Date: | 2022-09-30 |
| Earnings Estimate Avg: | -0.25 |
| Earnings Estimate Low: | -0.51 |
| Earnings Estimate High: | 0.10 |
| Earnings Estimate Year Ago Eps: | -0.25 |
| Earnings Estimate Number Of Analysts: | 7.00 |
| Revenue Estimate Avg: | 50370000.00 |
| Revenue Estimate Low: | 43000000.00 |
| Revenue Estimate High: | 58300000.00 |
| Revenue Estimate Number Of Analysts: | 7.00 |
| Revenue Estimate Growth: | 0.31 |
| Eps Trend Current: | -0.25 |
| Eps Trend7days Ago: | -0.25 |
| Eps Trend30days Ago: | -0.28 |
| Eps Trend60days Ago: | -0.29 |
| Eps Trend90days Ago: | -0.29 |
| Eps Revisions Up Last30days: | 1.00 |
| Date: | 2022-06-30 |
| Date: | 2022-03-31 |
| Date: | 2021-12-31 |
| Date: | 2019-09-30 |
| Period: | +1y |
| Revenue Estimate Avg: | 35130000.00 |
| Revenue Estimate Low: | 31800000.00 |
| Revenue Estimate High: | 38000000.00 |
| Revenue Estimate Number Of Analysts: | 4.00 |
| Revenue Estimate Growth: | 0.23 |
| Eps Trend7days Ago: | -0.28 |
| Eps Trend30days Ago: | -0.28 |
| Eps Trend60days Ago: | -0.28 |
| Eps Trend90days Ago: | -0.28 |
| Eps Revisions Up Last30days: | 1.00 |
| Date: | 2019-03-31 |
| Period: | +1q |
| Revenue Estimate Avg: | 28550000.00 |
| Revenue Estimate Low: | 27000000.00 |
| Revenue Estimate High: | 31000000.00 |
| Revenue Estimate Number Of Analysts: | 4.00 |
| Revenue Estimate Growth: | 0.18 |
| Date: | 2018-12-31 |
| Revenue Estimate Avg: | 28550000.00 |
| Revenue Estimate Low: | 27000000.00 |
| Revenue Estimate High: | 31000000.00 |
| Revenue Estimate Number Of Analysts: | 4.00 |
| Revenue Estimate Growth: | 0.18 |
| Date: | 2018-09-30 |
| Revenue Estimate Avg: | 28550000.00 |
| Revenue Estimate Low: | 27000000.00 |
| Revenue Estimate High: | 31000000.00 |
| Revenue Estimate Number Of Analysts: | 4.00 |
| Revenue Estimate Growth: | 0.18 |
| Eps Trend7days Ago: | -0.34 |
| Eps Trend30days Ago: | -0.34 |
| Eps Trend60days Ago: | -0.34 |
| Eps Trend90days Ago: | -0.34 |
| Eps Revisions Up Last30days: | 1.00 |
| Date: | 2019-03-31 |
| Eps Actual: | -0.15 |
| Date: | 2017-09-30 |
| Eps Actual: | -0.57 |
| Date: | 2016-09-30 |
| Eps Actual: | -0.55 |